# Vir Biotechnology, Inc.: Form 8-K, filed May 28, 2026

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2026-05-28
- Accepted by EDGAR: May 28, 2026, 09:01 ET
- Period: 2026-05-25
- Accession: 0001628280-26-038630
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/vir-20260525.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/vir-20260525.htm

Filed May 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-038630. Last ingested by Listed: Nov 4, 2026, 17:08 ET. No prices; not investment advice.